XML 485 R123.htm IDEA: XBRL DOCUMENT v3.22.4
Capital and funding - Summary of Combined Financial Information in Relation to HUL (Details) - EUR (€)
€ in Millions
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Disclosure of classes of share capital [line items]      
Non-current assets € 58,664 € 57,694  
Current assets 19,157 17,401  
Current liabilities (25,427) (24,778)  
Non-current liabilities (30,693) (30,571)  
Turnover 60,073 52,444 € 50,724
Profit after tax 8,269 6,621 6,073
Total comprehensive income 8,355 9,977 3,836
Equity at beginning of period (19,746) (17,655) (13,886)
Other comprehensive income (86) (3,356)  
Other movements in equity 136 [1] (154) [2] 232 [2]
Equity at end of period (21,701) (19,746) (17,655)
Non-controlling interests      
Disclosure of classes of share capital [line items]      
Profit after tax 627 572 492
Total comprehensive income 507 749 286
Equity at beginning of period (2,639) (2,389) (694)
Other movements in equity (107) [1] (7) [2] (48) [2]
Equity at end of period (2,680) (2,639) (2,389)
Subsidiaries with material non-controlling interests | Hindustan Unilever Limited      
Disclosure of classes of share capital [line items]      
Non-current assets 6,354 6,616  
Current assets 1,604 1,454  
Current liabilities (1,258) (1,212)  
Non-current liabilities (1,152) (1,231)  
Turnover 6,828 5,581  
Profit after tax 1,190 977  
Total comprehensive income 940 1,334  
Net increase/(decrease) in cash and cash-equivalents 95 (176)  
Subsidiaries with material non-controlling interests | Hindustan Unilever Limited | Non-controlling interests      
Disclosure of classes of share capital [line items]      
Profit after tax 454 372  
Equity at beginning of period (2,146) (1,978)  
Other comprehensive income (3) (3)  
Dividend paid to the non-controlling interest 395 326  
Currency translation 97 (131)  
Other movements in equity (4) 12  
Equity at end of period € (2,115) € (2,146) € (1,978)
[1] Includes the following items related to the acquisition of Nutrafol: €(269) million non-controlling interest purchase option in other reserves and €99 million non-controlling interest recognised on acquisition.
[2] 2021 includes a hyperinflation adjustment of €280 million and €82 million related to the Welly acquisition. 2020 includes €163 million paid for purchase of the non-controlling interest in Unilever Malaysia.